Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir dispersible tablets in young children with HIV
NCT05006170Phase 2Unknown
- Sponsor
- Chulalongkorn University
- Start
- Aug 2021
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
A Phase 2 trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by Chulalongkorn University. Status: unknown.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05006170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05006170.